This document provides an overview of a training module on proper prescribing of controlled prescription drugs. It discusses the objectives of the training, which are to discuss the controlled prescription drug epidemic, define misprescribing, compare the roles of the medical board and DEA, and determine one's risk for misprescribing. It also provides information on the rights and responsibilities around the materials, introduces the topics that will be covered, and gives instructions for how to complete the module.
Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treat...Carevive
Acute myelogenous leukemia (AML) primarily affects older adults with a median age of 67 years. Traditionally, older patients have not received intensive chemotherapy due to toxicity risks, but current research shows fit older patients who receive intensive chemotherapy have better outcomes than those who receive no treatment. Geriatric assessments are critical for determining treatment for older AML patients, as frailty is associated with poorer responses and survival. Assessments evaluate factors like activities of daily living, comorbidities, cognition, and quality of life. While comprehensive geriatric assessments are optimal, several screening tools can help hematologists evaluate fitness when determining AML treatment for older patients.
A consumer study prepared by PwC to investigate how behavioral, regulatory, and technological disruption are changing consumer's approaches to managing their health.
PYA Principal J. Michael Keegan, MD, recently presented “Pacing Volume-to-Value Transition” and “The ROI of Avoiding Antibiotic Overuse” at the AlaHA Annual Meeting, June 8-11, 2016. The presentation focused on the importance of antibiotic stewardship programs (ASP) for population health. The presentation explained:
Why the Centers for Medicare & Medicaid Services is proposing a requirement that hospitals implement ASPs to stem the rise of resistant bacteria.
Why PYA is invested in offering hospitals a proven program for improving patient safety while saving costs.
What constitutes a successful ASP.
HCL's transformational Patient's first approach to HealthcareDebanjan Munsi
Digital Care management is the new buzzword in Healthcare technology, with the advent of digital technologies that track patient health, medicine subscriptions, dosages and create customized tracking, monitoring & delivery programs with regular dosage reminders, data driven insights on health vitals and patient routing to best possible treatment locations. Digital care management can not only reduce costs, but increase the vitality of healthcare programs, making them more efficient, decisive and customer friendly.
The document discusses the medical home model as a disruptive innovation for primary care. It proposes paying primary care physicians for coordinating patient care and managing health outcomes and costs through a medical home model. This shifts care from a specialist-focused model to a simpler, rules-based primary care model. The medical home aims to provide integrated, whole-person care through teams led by primary care physicians. It also discusses pilots of medical homes, challenges, and the potential for cost savings through reduced errors, care gaps, and procedures.
Opioid Epidemic - Causes, Impact and FutureCitiusTech
In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
Painsolver is a clinical decision support tool designed to improve healthcare outcomes for low back pain. It addresses limitations in how patient care is currently managed by providing evidence-based guidance, integrating recommendations into workflows, and promoting shared decision making between providers and patients. The tool aims to help organizations and providers succeed under emerging pay-for-performance models by enhancing outcomes and reducing costs over a patient's lifetime. Vertelogics believes Painsolver can help providers and organizations not just survive but thrive as the healthcare system shifts its focus to outcomes-based reimbursement.
This document summarizes key topics from a presentation on health care bargaining trends for unions and employers. It discusses rising health care costs outpacing inflation, the impact of the Affordable Care Act, and cost containment strategies being implemented or considered like reference pricing, narrow networks, and on-site clinics. Projected medical trend rates are provided from 2007 to 2016 with the highest being in the West region. The potential effects of the ACA excise tax on health plans are also reviewed.
Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treat...Carevive
Acute myelogenous leukemia (AML) primarily affects older adults with a median age of 67 years. Traditionally, older patients have not received intensive chemotherapy due to toxicity risks, but current research shows fit older patients who receive intensive chemotherapy have better outcomes than those who receive no treatment. Geriatric assessments are critical for determining treatment for older AML patients, as frailty is associated with poorer responses and survival. Assessments evaluate factors like activities of daily living, comorbidities, cognition, and quality of life. While comprehensive geriatric assessments are optimal, several screening tools can help hematologists evaluate fitness when determining AML treatment for older patients.
A consumer study prepared by PwC to investigate how behavioral, regulatory, and technological disruption are changing consumer's approaches to managing their health.
PYA Principal J. Michael Keegan, MD, recently presented “Pacing Volume-to-Value Transition” and “The ROI of Avoiding Antibiotic Overuse” at the AlaHA Annual Meeting, June 8-11, 2016. The presentation focused on the importance of antibiotic stewardship programs (ASP) for population health. The presentation explained:
Why the Centers for Medicare & Medicaid Services is proposing a requirement that hospitals implement ASPs to stem the rise of resistant bacteria.
Why PYA is invested in offering hospitals a proven program for improving patient safety while saving costs.
What constitutes a successful ASP.
HCL's transformational Patient's first approach to HealthcareDebanjan Munsi
Digital Care management is the new buzzword in Healthcare technology, with the advent of digital technologies that track patient health, medicine subscriptions, dosages and create customized tracking, monitoring & delivery programs with regular dosage reminders, data driven insights on health vitals and patient routing to best possible treatment locations. Digital care management can not only reduce costs, but increase the vitality of healthcare programs, making them more efficient, decisive and customer friendly.
The document discusses the medical home model as a disruptive innovation for primary care. It proposes paying primary care physicians for coordinating patient care and managing health outcomes and costs through a medical home model. This shifts care from a specialist-focused model to a simpler, rules-based primary care model. The medical home aims to provide integrated, whole-person care through teams led by primary care physicians. It also discusses pilots of medical homes, challenges, and the potential for cost savings through reduced errors, care gaps, and procedures.
Opioid Epidemic - Causes, Impact and FutureCitiusTech
In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
Painsolver is a clinical decision support tool designed to improve healthcare outcomes for low back pain. It addresses limitations in how patient care is currently managed by providing evidence-based guidance, integrating recommendations into workflows, and promoting shared decision making between providers and patients. The tool aims to help organizations and providers succeed under emerging pay-for-performance models by enhancing outcomes and reducing costs over a patient's lifetime. Vertelogics believes Painsolver can help providers and organizations not just survive but thrive as the healthcare system shifts its focus to outcomes-based reimbursement.
This document summarizes key topics from a presentation on health care bargaining trends for unions and employers. It discusses rising health care costs outpacing inflation, the impact of the Affordable Care Act, and cost containment strategies being implemented or considered like reference pricing, narrow networks, and on-site clinics. Projected medical trend rates are provided from 2007 to 2016 with the highest being in the West region. The potential effects of the ACA excise tax on health plans are also reviewed.
Tips to jumpstart your telemedicine program for addictionVSee
To carry on the discussion in real life, join us at Telehealth and Secrets to Success Conference, Sept 20-22, Silicon Valley:
https://goo.gl/95zHZG
For more information of the webinar such as recording and transcript, please visit:
https://vsee.com/blog/tips-jumpstart-telemedicine-program-addiction/
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
This case study describes how a national multi-site healthcare provider was able to increase EBITDA by $3.38 million, free cash flow by $8 million, and exit value by $31.3 million through active management and minor tweaks to their benefits strategy over 5 years. This included aggregating multiple plans into a single plan, implementing new data and analytics tools, and ongoing minor changes to incentivize smart member decisions and remove unnecessary costs and waste while maintaining low employee premium increases and decreasing payroll contributions.
US Goverment Accountability Office Telehealth reportVSee
This document summarizes a Government Accountability Office report on telehealth and remote patient monitoring use in Medicare and selected federal programs. It finds that while telehealth and remote patient monitoring have potential to improve care, low utilization exists in Medicare due to coverage and payment barriers. Emerging payment models may expand use by addressing restrictions. The report also describes oversight of Medicare telehealth payments and factors affecting use cited by provider, patient, and payer associations.
This document provides an overview of national and local health information exchange (HIE) initiatives. It begins with learning objectives about differentiating national HIE efforts, current HIE adoption levels, and drivers, challenges, and trends of HIE. The document then discusses the various "apples and oranges" of HIE collaborations, trusts, and exchanges. Facts and figures about national and Massachusetts HIE participation and use are presented. Finally, the document outlines drivers, challenges, and emerging trends of HIE and describes examples of regional HIEs in Massachusetts.
ODANO (Oncology Drug Access Navigators of Ontario) is a provincial organization that provides support and advocacy to help cancer patients access the medications they need. It has over 50 members across various regions of Ontario who help navigate public and private drug coverage plans and work with patients' treatment teams. The organization faces challenges with wait times for public drug plans and lack of direct communication with private insurers, and works on case studies to help patients receive adequate funding for their cancer treatments.
This document summarizes a presentation on legislative and medication trends impacting third-party payers. It discusses several topics: physician dispensing and repackaged medications, opioid utilization, treatment guidelines and closed formularies, and compounded medications. For each topic, it outlines related legislative strategies and regulatory approaches taken by different states to influence costs and utilization for third-party payers. The presentation aims to identify issues relevant to third-party payers and explain how they can shape legislative and regulatory outcomes.
Novel treatment options for acute hf a multidisciplinary approach (printer f...drucsamal
This document discusses a CME activity on novel treatment options for acute heart failure using a multidisciplinary approach. It provides learning objectives, faculty disclosures, and instructions for participating physicians to earn CME credits. The activity aims to evaluate current and emerging therapies for acute heart failure and summarize strategies for multidisciplinary management from the emergency department through discharge and at-home care. The discussion will focus on improving outcomes for the over 1 million patients hospitalized annually for acute heart failure in the United States.
The document discusses perspectives on risk from various healthcare stakeholders. It finds that while stakeholders generally expect longer lifespans, opinions diverge on expectations for curing diseases like cancer. U.S. payers and biopharma executives are less optimistic than others about cost-effective healthcare. Patients want information on medication benefits but are less confident in understanding risks. Both U.S. and U.K. patients want new drugs faster but many also think approval processes don't adequately balance safety. Stakeholders must work together to better understand differing views of risk.
Behavioral Health Industry Insights - 2016Duff & Phelps
Over the last 50 years, the number of inpatient psychiatric facilities in the US, mostly state-run hospitals, has sharply declined due to deinstitutionalization and Medicaid policies like the IMD Exclusion. Deinstitutionalization reduced state-run psychiatric beds by over 90% from 1955 to 2012. The IMD Exclusion further curtailed Medicaid reimbursement for large facilities, shifting treatment to community-based outpatient care. However, this has left many areas without adequate inpatient beds. Recent policy changes now allow Medicaid reimbursement for some short-term inpatient mental health and addiction services for adults aged 21-64 which could help address gaps.
Four Effective Opioid Interventions for Healthcare LeadersHealth Catalyst
The crisis of opioid abuse in the U.S. is well known. What may not be so well known are the ways for clinicians and healthcare systems to minimize misuse of these addictive drugs. This article describes the risks for patients when they are prescribed opioids and the need for opioid intervention. It offers four approaches that healthcare systems can take to tackle the crisis while still relieving pain and suffering for the patients they serve:
Use data and analytics to inform strategies that reduce opioid availability
Adopt prescription drug monitoring programs to prevent misuse
Adopt evidence-based guidelines
Consider promising state strategies for dealing with prescription opioid overdose
Opioid misuse is a public health epidemic, but treatments are available and it’s time for those involved in the delivery of healthcare to change practices.
Improving statin adherence through interactive voice technology & barrier bre...George Van Antwerp
This document discusses using interactive voice response (IVR) technology to improve statin adherence through targeted communications. It summarizes a statin adherence program at Kaiser Permanente Riverside that used IVR reminder calls, a barrier survey, and mail order options. The program reached 88% of the target population and 71% heard messages. It found the main barriers to adherence were not knowing to refill, cost, and convenience issues. Targeted messaging increased adherence, with 27% of those initially not intending to refill doing so after barrier messages. The program demonstrated how data and continuous improvement can enhance IVR's ability to personalize outreach at scale.
The document discusses ways to reform private health insurance (PHI) in Australia to better balance affordability and value for consumers. It provides background on the PHI industry and findings from consumer surveys. Key points include: consumers value predictability and treatment for urgent conditions but affordability is a major issue; online sources and health funds are preferred for information but have limitations; and changes are needed to simplify complex products and address rising costs while maintaining coverage levels important to consumers like protection from high costs.
An ACO Case Study: Quality Improvement in HealthcareHealth Catalyst
This document discusses OSF Healthcare's palliative care program and efforts to improve care coordination and advance care planning. OSF implemented a technology-enabled solution to identify high-risk patients, drive community engagement in advance care planning conversations, and integrate patient information across settings. Outcomes included exceeding targets for the number of patients completing advance care planning. Moving forward, OSF aims to expand these efforts and further analyze impacts on patient outcomes and experience of care.
This document summarizes a presentation on insights from state policies and interventions to curb prescription drug overdoses. It describes several interventions:
1) PRIMUM, a system in North Carolina that alerts prescribers to patients' risk of misusing or abusing opioids at the point of care.
2) A project in Rhode Island that developed protocols to improve opioid prescription safety for trauma patients, including alerts if prescriptions exceed dosage thresholds and requiring naloxone co-prescriptions.
3) A study in Pennsylvania that used Medicaid claims data to identify risk factors for opioid overdoses, such as high dosage and multiple prescribers/pharmacies, to target high-risk patients.
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...Forward360 LLC
Electronic prescribing of controlled substances (EPCS) provides opportunities to improve safety and reduce fraud compared to paper prescriptions. EPCS is now legal in all but two states, though adoption has been limited due to lack of awareness, competing IT priorities, and geographic disparities between enabled pharmacies and providers. Experiences from providers and pharmacies already using EPCS show benefits like increased accountability, accuracy, and reduced costs. Widespread adoption could save up to $700 million annually through improved medication management.
Understand what consumers value most when managing their health and how much additional responsibility they’re willing to take on to reduce the cost of their healthcare.
Physician Leadership in Medicine's New Ageflasco_org
The document discusses the American Medical Association's (AMA) work on various issues including: advocating for physicians on regulatory and payment issues; fighting health insurance consolidation; addressing burnout and the burden of electronic health records; priorities under the Medicare Access and CHIP Reauthorization Act (MACRA); confronting chronic disease; efforts to address the opioid epidemic; supporting digital innovation in healthcare; and transforming medical education. The AMA is the largest physician organization in the US and represents physicians through its House of Delegates and Board of Trustees.
PYA Monitors Topics on Healthcare Radar at AlaHAPYA, P.C.
PYA recently presented “Blips on the Radar—Ground Clutter or Looming Crisis?” at the 2014 Alabama Hospital Association Annual Meeting. Topics covered included:
ICD-10—What now?
Hospital-Physician Transactions—The compliance wheel
Value-Based Payments—What’s up with that?
Physician Differentiation—What sets doctors apart?
The document discusses the rational use of drugs and outlines several key points:
1) Rational drug use means prescribing the appropriate medication based on a patient's clinical needs at the lowest cost.
2) Irrational drug use can occur when patients do not receive the proper drug, dose, duration or when higher cost drugs are used unnecessarily.
3) Promoting rational drug use requires addressing factors like a lack of education, diagnostic facilities, and effective regulation of drug promotion.
A prescription is a written or verbal order from a licensed medical professional for a medication. Prescriptions have been used since ancient times and Latin was adopted as the standard language. Prescriptions must clearly identify the patient and include details like drug name, dose, frequency, and prescriber information. There are different types of prescriptions for different settings like hospitals, general practice, and private use. Proper prescription writing aims to prevent errors by using unambiguous terminology and formats. Common errors in drug administration must be reported to allow for proper management.
Tips to jumpstart your telemedicine program for addictionVSee
To carry on the discussion in real life, join us at Telehealth and Secrets to Success Conference, Sept 20-22, Silicon Valley:
https://goo.gl/95zHZG
For more information of the webinar such as recording and transcript, please visit:
https://vsee.com/blog/tips-jumpstart-telemedicine-program-addiction/
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
This case study describes how a national multi-site healthcare provider was able to increase EBITDA by $3.38 million, free cash flow by $8 million, and exit value by $31.3 million through active management and minor tweaks to their benefits strategy over 5 years. This included aggregating multiple plans into a single plan, implementing new data and analytics tools, and ongoing minor changes to incentivize smart member decisions and remove unnecessary costs and waste while maintaining low employee premium increases and decreasing payroll contributions.
US Goverment Accountability Office Telehealth reportVSee
This document summarizes a Government Accountability Office report on telehealth and remote patient monitoring use in Medicare and selected federal programs. It finds that while telehealth and remote patient monitoring have potential to improve care, low utilization exists in Medicare due to coverage and payment barriers. Emerging payment models may expand use by addressing restrictions. The report also describes oversight of Medicare telehealth payments and factors affecting use cited by provider, patient, and payer associations.
This document provides an overview of national and local health information exchange (HIE) initiatives. It begins with learning objectives about differentiating national HIE efforts, current HIE adoption levels, and drivers, challenges, and trends of HIE. The document then discusses the various "apples and oranges" of HIE collaborations, trusts, and exchanges. Facts and figures about national and Massachusetts HIE participation and use are presented. Finally, the document outlines drivers, challenges, and emerging trends of HIE and describes examples of regional HIEs in Massachusetts.
ODANO (Oncology Drug Access Navigators of Ontario) is a provincial organization that provides support and advocacy to help cancer patients access the medications they need. It has over 50 members across various regions of Ontario who help navigate public and private drug coverage plans and work with patients' treatment teams. The organization faces challenges with wait times for public drug plans and lack of direct communication with private insurers, and works on case studies to help patients receive adequate funding for their cancer treatments.
This document summarizes a presentation on legislative and medication trends impacting third-party payers. It discusses several topics: physician dispensing and repackaged medications, opioid utilization, treatment guidelines and closed formularies, and compounded medications. For each topic, it outlines related legislative strategies and regulatory approaches taken by different states to influence costs and utilization for third-party payers. The presentation aims to identify issues relevant to third-party payers and explain how they can shape legislative and regulatory outcomes.
Novel treatment options for acute hf a multidisciplinary approach (printer f...drucsamal
This document discusses a CME activity on novel treatment options for acute heart failure using a multidisciplinary approach. It provides learning objectives, faculty disclosures, and instructions for participating physicians to earn CME credits. The activity aims to evaluate current and emerging therapies for acute heart failure and summarize strategies for multidisciplinary management from the emergency department through discharge and at-home care. The discussion will focus on improving outcomes for the over 1 million patients hospitalized annually for acute heart failure in the United States.
The document discusses perspectives on risk from various healthcare stakeholders. It finds that while stakeholders generally expect longer lifespans, opinions diverge on expectations for curing diseases like cancer. U.S. payers and biopharma executives are less optimistic than others about cost-effective healthcare. Patients want information on medication benefits but are less confident in understanding risks. Both U.S. and U.K. patients want new drugs faster but many also think approval processes don't adequately balance safety. Stakeholders must work together to better understand differing views of risk.
Behavioral Health Industry Insights - 2016Duff & Phelps
Over the last 50 years, the number of inpatient psychiatric facilities in the US, mostly state-run hospitals, has sharply declined due to deinstitutionalization and Medicaid policies like the IMD Exclusion. Deinstitutionalization reduced state-run psychiatric beds by over 90% from 1955 to 2012. The IMD Exclusion further curtailed Medicaid reimbursement for large facilities, shifting treatment to community-based outpatient care. However, this has left many areas without adequate inpatient beds. Recent policy changes now allow Medicaid reimbursement for some short-term inpatient mental health and addiction services for adults aged 21-64 which could help address gaps.
Four Effective Opioid Interventions for Healthcare LeadersHealth Catalyst
The crisis of opioid abuse in the U.S. is well known. What may not be so well known are the ways for clinicians and healthcare systems to minimize misuse of these addictive drugs. This article describes the risks for patients when they are prescribed opioids and the need for opioid intervention. It offers four approaches that healthcare systems can take to tackle the crisis while still relieving pain and suffering for the patients they serve:
Use data and analytics to inform strategies that reduce opioid availability
Adopt prescription drug monitoring programs to prevent misuse
Adopt evidence-based guidelines
Consider promising state strategies for dealing with prescription opioid overdose
Opioid misuse is a public health epidemic, but treatments are available and it’s time for those involved in the delivery of healthcare to change practices.
Improving statin adherence through interactive voice technology & barrier bre...George Van Antwerp
This document discusses using interactive voice response (IVR) technology to improve statin adherence through targeted communications. It summarizes a statin adherence program at Kaiser Permanente Riverside that used IVR reminder calls, a barrier survey, and mail order options. The program reached 88% of the target population and 71% heard messages. It found the main barriers to adherence were not knowing to refill, cost, and convenience issues. Targeted messaging increased adherence, with 27% of those initially not intending to refill doing so after barrier messages. The program demonstrated how data and continuous improvement can enhance IVR's ability to personalize outreach at scale.
The document discusses ways to reform private health insurance (PHI) in Australia to better balance affordability and value for consumers. It provides background on the PHI industry and findings from consumer surveys. Key points include: consumers value predictability and treatment for urgent conditions but affordability is a major issue; online sources and health funds are preferred for information but have limitations; and changes are needed to simplify complex products and address rising costs while maintaining coverage levels important to consumers like protection from high costs.
An ACO Case Study: Quality Improvement in HealthcareHealth Catalyst
This document discusses OSF Healthcare's palliative care program and efforts to improve care coordination and advance care planning. OSF implemented a technology-enabled solution to identify high-risk patients, drive community engagement in advance care planning conversations, and integrate patient information across settings. Outcomes included exceeding targets for the number of patients completing advance care planning. Moving forward, OSF aims to expand these efforts and further analyze impacts on patient outcomes and experience of care.
This document summarizes a presentation on insights from state policies and interventions to curb prescription drug overdoses. It describes several interventions:
1) PRIMUM, a system in North Carolina that alerts prescribers to patients' risk of misusing or abusing opioids at the point of care.
2) A project in Rhode Island that developed protocols to improve opioid prescription safety for trauma patients, including alerts if prescriptions exceed dosage thresholds and requiring naloxone co-prescriptions.
3) A study in Pennsylvania that used Medicaid claims data to identify risk factors for opioid overdoses, such as high dosage and multiple prescribers/pharmacies, to target high-risk patients.
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...Forward360 LLC
Electronic prescribing of controlled substances (EPCS) provides opportunities to improve safety and reduce fraud compared to paper prescriptions. EPCS is now legal in all but two states, though adoption has been limited due to lack of awareness, competing IT priorities, and geographic disparities between enabled pharmacies and providers. Experiences from providers and pharmacies already using EPCS show benefits like increased accountability, accuracy, and reduced costs. Widespread adoption could save up to $700 million annually through improved medication management.
Understand what consumers value most when managing their health and how much additional responsibility they’re willing to take on to reduce the cost of their healthcare.
Physician Leadership in Medicine's New Ageflasco_org
The document discusses the American Medical Association's (AMA) work on various issues including: advocating for physicians on regulatory and payment issues; fighting health insurance consolidation; addressing burnout and the burden of electronic health records; priorities under the Medicare Access and CHIP Reauthorization Act (MACRA); confronting chronic disease; efforts to address the opioid epidemic; supporting digital innovation in healthcare; and transforming medical education. The AMA is the largest physician organization in the US and represents physicians through its House of Delegates and Board of Trustees.
PYA Monitors Topics on Healthcare Radar at AlaHAPYA, P.C.
PYA recently presented “Blips on the Radar—Ground Clutter or Looming Crisis?” at the 2014 Alabama Hospital Association Annual Meeting. Topics covered included:
ICD-10—What now?
Hospital-Physician Transactions—The compliance wheel
Value-Based Payments—What’s up with that?
Physician Differentiation—What sets doctors apart?
The document discusses the rational use of drugs and outlines several key points:
1) Rational drug use means prescribing the appropriate medication based on a patient's clinical needs at the lowest cost.
2) Irrational drug use can occur when patients do not receive the proper drug, dose, duration or when higher cost drugs are used unnecessarily.
3) Promoting rational drug use requires addressing factors like a lack of education, diagnostic facilities, and effective regulation of drug promotion.
A prescription is a written or verbal order from a licensed medical professional for a medication. Prescriptions have been used since ancient times and Latin was adopted as the standard language. Prescriptions must clearly identify the patient and include details like drug name, dose, frequency, and prescriber information. There are different types of prescriptions for different settings like hospitals, general practice, and private use. Proper prescription writing aims to prevent errors by using unambiguous terminology and formats. Common errors in drug administration must be reported to allow for proper management.
The document summarizes key aspects of prescriptions, including the prescription process, elements of a prescription, pharmacy abbreviations, labels, and HIPAA regulations. It describes the roles of pharmacy technicians in receiving prescriptions, entering insurance and patient information, preparing and checking prescriptions, and providing counseling. Technicians must verify prescription accuracy and refer any issues to pharmacists. Labels contain required information and directions must use verbs and avoid abbreviations.
a beautiful ppt, illustrating the principles for prescribing, current concepts for clinical decision making, for practicing medicine and health care planning worldwide...
A prescription is a written order from a physician directing a pharmacist to dispense medication. There are two types: pre-compounded prescriptions for already prepared drugs, and extemporaneous prescriptions where the pharmacist prepares the medication. A prescription should include the date, prescribing doctor's information, patient information, drug name and dosage, directions, and doctor's signature. Abbreviations are commonly used in prescriptions to save space. Rational prescribing fulfills medical criteria while irrational prescribing inappropriately uses drugs.
The document discusses the concept of essential medicines and rational use of drugs. It defines essential medicines as those that meet the priority health care needs of the population. The WHO publishes a Model List of Essential Medicines every two years to guide countries in developing their own national lists. Educational, managerial, economic and regulatory strategies can be used to promote rational drug use and selection of cost-effective treatments. Pharmacists can play a role through drug selection, inventory control, patient education, and pharmaceutical care.
Definition of prescription, Types, Difference between them.
Analyzing some prescriptions and their errors, comparing them with an ideal one.
Methods we should take to minimize those errors.
go to www.medicaldump.com to download this file and check out other medical powerpoints, medical powerpoint templates, medical pdfs and all other medical documents.
Consumer health: time for a regulatory re-think? is a report by RB in association with PAGB, written by the Economist Intelligence Unit. It looks at the changing healthcare environment and the role self-care plays and efforts at regulatory harmonisation, the barriers they have encountered, and prospects for the future.
EHR Meaningful Use ONC Policy Commitee June 16 2009Michael Duffy
The document outlines proposed meaningful use criteria for 2011, which focus on improving quality, safety, efficiency, engaging patients and families, improving care coordination, improving population and public health, and ensuring privacy and security protections. The criteria include objectives like capturing data in coded formats, incorporating lab results into EHRs, providing patients electronic access to health information, and exchanging key clinical information with other providers. Measures are proposed to track metrics like controlled diabetes and blood pressure rates, medication reconciliation, and electronic reporting of immunizations and lab results.
1) The document discusses how health information technology (HIT), such as electronic health records (EHRs) and health information exchanges (HIEs), has the potential to influence health reform efforts in the United States by reducing costs, increasing access to care, and improving quality of care.
2) The Affordable Care Act includes provisions and financial incentives to encourage widespread adoption of EHRs and use of HIT. Meaningful use criteria aim to ensure EHRs improve safety, quality, and coordination of care.
3) HIT such as EHRs and HIEs could transform healthcare by giving providers access to complete patient information, reducing medical errors, duplicative tests, and costs
The document summarizes the Orphan Drug Act of 1983 and its impact. It provides incentives like 7 years of marketing exclusivity and tax credits to stimulate development of drugs for rare diseases defined as affecting fewer than 200,000 people. Since 1983, over 1000 designations and 200 product approvals have occurred. While the Act has met its objectives, concerns around the high costs of orphan drugs and determining appropriate access and reimbursement are discussed.
The document outlines proposed meaningful use criteria and objectives for 2011 that focus on improving quality, safety, efficiency, engaging patients and families, improving care coordination, improving population and public health, and ensuring privacy and security protections. It provides details on specific objectives and associated measures within each category. The summary recommends having a clear understanding of the meaningful use requirements and vendor solutions to meet them.
eDetailing: A Strategic Analysis Of Implementation And ROI (mini)Eularis
Eularis provides a comprehensive insight into the subject of Pharmaceutical detailing using the Internet. As the vast majority of eDetailing pilots have taken place in the US, the report looks at the likelihood of European Pharmaceutical companies following suit. Return on Investment (ROI) is also important. This report discusses the available evidence on ROI and illustrates some models that can be used.
Eularis made extensive efforts to provide the most insightful information about this fast moving subject. This involved:
* Surveying over 200 UK-based general practitioners about their attitudes to Pharmaceutical sales representatives and eDetailing,
* Carefully assessing the current regulatory environment in the UK and how eDetailing programs could be affected,
* Sourcing case studies of ROI from the USA,
* Extensive research into vendor companies and their market positions,
* Strategic considerations and advice.
This study compared information on medication use and drug-related problems (DRPs) obtained via a patient questionnaire versus a patient interview. 97 patients aged 65+ years with polypharmacy or geriatric problems completed the questionnaire and were then interviewed. There was 87.6% agreement between the questionnaire and interview for reported medications. More medications and DRPs were reported in interviews than questionnaires. Agreement on complete medication lists was 45.4% of patients. Vulnerable patients with many chronic diseases or medications showed lower agreement. The questionnaire provided reasonably similar but not identical information as interviews and may be suitable for medication reviews in most patients.
Blazing New Trails: Shifting the Focus on Alcohol and Drugsnashp
Presented at the National Academy for State Health Policy's 20th Annual State Health Policy Conference in Denver, Colorado. Authors: Barbara Cimaglio, Sally Fogerty, BSN, M.Ed., John C. Higgins-Biddle, Ph.D.
This document discusses medication errors that can occur in hospitals. It defines medication errors as any error in prescribing, dispensing, or administering drugs, regardless of whether harm occurs. Medication errors are a major cause of preventable patient harm. The document classifies medication errors as mistakes, slips, or lapses, depending on where the error occurs in the medication use process. It also discusses different ways medication errors have been estimated to cause deaths in other countries to highlight the significant impact of these errors.
The document discusses perceptions of value and relationships among biopharmaceutical stakeholders. It finds that key stakeholders have different definitions of "value" in healthcare, with outcomes being a more important part of biopharma executives' definitions compared to other groups. Physicians are widely perceived as adding the most value to healthcare. While stakeholders generally agree on the benefits of prescription medications, managed care executives are less convinced of patients' spending on medications being worth it. The document also examines stakeholders' perceptions of each other's effectiveness in areas like patient education and understanding needs. Most groups feel patients can do more to improve health behaviors and outcomes.
Primary medical care settings are ideal for treating chronic illnesses but are underutilized venues for addressing this particular chronic disease. Addiction treatment specialists are too few and many patients find this path to be unacceptable. The question becomes: how to get primary care medical providers to integrate the treatment of patients with opioid use disorders into their practices?
Different ways to accomplish this were the topic of the Louis Kolodner Memorial Lecture at MedChi for the second year in a row. Last year, Dr. Michael Fingerhood described the model that he has developed at Johns Hopkins Medicine. This year, Dr. Richard Schottenfeld, now the Chief of Psychiatry at Howard University, presented research studies done by Yale University and other centers. These studies demonstrated four successful interventions:
Methadone given to already stabilized opioid addiction patients in a primary care setting instead of a specialized opioid treatment program (OTP)
Buprenorphine along with medical counseling given in a primary care setting
An initial dose of buprenorphine given in a hospital emergency department along with a next-day follow up appointment for ongoing treatment
Injectable naltrexone, although more difficult to initiate for patients than was buprenorphine, was effective for those patients who were able to start it
Two barriers that needed to be reduced to achieve these successes were the disinclination of providers to use these medications and general pessimism about the prognosis of opioid use disorders. My hope is that as more successes are demonstrated, these barriers will slowly be lowered. For those interested in more details about these studies, I invite you to access the lecture slides, available here.
Over 70% of ER, urgent care, and doctor visits can be safely handled over the phone. The healthiestyou platform provides 24/7 access to licensed US doctors through phone, video, or email consultations to diagnose, prescribe medications, and provide medical advice for common conditions like allergies and bronchitis. It offers a personalized online wellness program and prescription drug price comparison tool to empower people to improve their health while potentially reducing costs. Member surveys found high rates of satisfaction and that issues were typically resolved in under 30 minutes through the telehealth service.
Over 70% of ER, urgent care, and doctor visits can be safely handled over the phone. The healthiestyou platform provides 24/7 access to licensed US doctors through phone, video, or email who can diagnose, prescribe, and treat the top 9 reasons for doctor visits such as allergies and bronchitis. Studies have found telehealth reduces costs by 21% compared to in-person visits. The healthiestyou program offers personalized online wellness programs and resources designed by Dr. Kelly Traver to empower individuals to achieve their health goals through weekly action plans and tracking progress.
Preventing Medication Errors: A $21 Billion OpportunityHealth Catalyst
With a potential industry-wide savings of almost $21 billion and an impact on more than seven million patient lives, preventing harmful medication error is a significant improvement opportunity for health systems. Also known as adverse drugs events (ADEs), harmful medication errors comprise about 37 percent of all medical harm. Approximately 50 percent of ADEs are preventable, making their reduction a highly impactable area of patient safety.
Current data and analytics workflow tools are making ADE surveillance, monitoring, and prevention increasingly more effective with four key capabilities:
Perspective surveillance for ADEs and identification of previously undescribed ADEs.
Identification of the root cause of many ADEs by drug class.
Prescription at appropriate doses for patients with compromised kidney or liver functions.
Identification of different types of harm to find causes.
Small-area analysis has revealed large variations in medical practice styles between geographical areas, especially for conditions with uncertain treatment effectiveness. The availability of healthcare services leads to more use of those services. Outcomes research analyzes real-world healthcare data to help patients make informed decisions based on treatment risks and benefits. Reporting errors and outcomes can drive quality improvement, but biases and inequities must also be addressed.
The document outlines a discussion on developing a universal pharmacare program in Canada, including reviewing different models proposed, lessons from international programs, and perspectives from mental health advocates. A vision and principles for a potential universal pharmacare plan are proposed that emphasize equitable access to necessary medications for all Canadians through a publicly-funded program. Next steps discussed include finalizing a report and seeking opportunities to promote the proposed approach.
This document discusses regulatory inefficiencies surrounding companion diagnostics and laboratory developed tests (LDTs) in the United States. It uses the case study of Genentech's drug MPDL3280A and its companion diagnostic to show that the FDA thoroughly regulates companion diagnostics but provides no oversight of clinical validity for LDTs. This allows multiple competing diagnostic tests to be used without proof of efficacy. The document also compares healthcare systems and technology assessment processes in the US, UK, and France to illustrate decentralized decision making in the US compared to centralized bodies in other countries.
This document summarizes a presentation on urine drug testing and monitoring prescription drug use. It discusses how prescription drug monitoring programs identify, investigate, and address fraud, waste and abuse related to prescription drug use and urine drug testing. It outlines trends seen in urine drug testing results that indicate issues with adherence, illicit drug use, and inconsistencies between prescribed medications and test results. Best practices are discussed for utilizing utilization review, case management, and other tools to help ensure appropriate use of medications and compliance with treatment regimens. The impacts of compounds, opioids, and long term opioid use are also addressed.
Similar to Proper prescribing module1_revised v2 (20)
Whole body ct adult versus ped centers (iep)bahlinnm
1) The study analyzed over 30,000 pediatric trauma patients treated at level I or II adult or pediatric trauma centers to compare the use of whole body CT (WBCT) scans between facilities.
2) It found WBCT scans were used significantly more often on pediatric patients treated at adult trauma centers (31.4%) compared to pediatric centers (17.6%).
3) After adjusting for factors, pediatric patients treated at adult centers were 1.8 times more likely to receive a WBCT, increasing their radiation risk without improving outcomes, as mortality did not differ between the groups. The study concludes guidelines are needed to minimize unnecessary WBCT use across centers.
This document discusses isolated head injuries in pediatric trauma patients and the association with shock and hypotension. The key points are:
1) A study found that among pediatric patients with isolated head injuries, rates of hypotension were highest in those aged 0-4 years, with 1/3 of hypotension cases associated with isolated head injuries in that age group.
2) Several potential causes for this association between isolated head injuries and hypotension in young pediatric patients were hypothesized, including neurogenic or autonomic responses.
3) Due to the risks of cerebral edema from large fluid volumes, providers may need to adjust treatment to include early vasopressors or anticholinergic drugs to support blood pressure in these
Vanderbilt is implementing a new CME attendance recording system that allows participants to text their attendance to update their transcript in real time and manage external credits online. To use the new system, users must log into the CME website with their VUnetID and ePassword, enter their cell phone number, and save the toll-free number 855-776-6263 in their phone so they can text their attendance at future sessions instead of using sign-in sheets.
The internal educational program (IEP) of Vanderbilt University's Division of Trauma, Emergency Surgery and Surgical Critical Care aims to provide educational opportunities on topics related to trauma care from pre-hospital care to post-discharge requirements. The IEP will explore various areas of interest throughout the year and outline the full continuum of care provided to trauma patients. The IEP involves the trauma team, which consists of physicians, nurses, and other specialists from various departments. The overall goal is to continuously improve trauma patient care and reduce injuries in the local region.
The internal educational program (IEP) of Vanderbilt University's Division of Trauma, Emergency Surgery and Surgical Critical Care aims to provide educational opportunities on topics related to trauma care from pre-hospital care to post-discharge requirements. The IEP will outline the care provided to trauma patients from point of injury through completion of care. The trauma team includes surgeons, nurses, and liaisons from emergency medicine, orthopedics, neurosurgery, anesthesia, and radiology, with the shared goal of improving trauma patient care in a consistent and caring manner and preventing injuries in the local region. Participants are asked to review provided materials and complete an evaluation.
This document discusses the importance of dental and vision care, and challenges that homeless individuals face in accessing these services. It notes that dental problems can cause pain, infection, and negatively impact quality of life and employment prospects. Similarly, untreated vision issues affect daily functioning and long-term health. However, many homeless people lack insurance or ability to pay for these services. The document describes innovative programs that health care for the homeless clinics have implemented to improve access, such as on-site dental and vision clinics, mobile services, and partnerships with outside providers. It emphasizes the importance of preventive care and dedicated clinics that understand homeless patients' needs.
This document outlines a planning worksheet to link learning objectives with educational activities and assessment plans. The worksheet lists learning objectives in the first column and pairs them with corresponding educational activities in the second column and assessment strategies in the third column to evaluate student learning and achievement of objectives.
This document provides guidance for course directors on assessment strategies for Advanced Clinical Electives (ACE) and Acting Internships (AI) at Vanderbilt School of Medicine. It emphasizes that assessment drives learning and should serve both summative and formative functions. The document outlines best practices for assessment including linking learning objectives to instructional activities and assessments, using multiple assessment methods, providing timely feedback, and ensuring fairness and consistency across courses. Examples are provided to illustrate how learning objectives can be aligned with educational activities and assessments. The overall message is that assessment is important for evaluating student progress and should be designed to both evaluate learning and guide future improvement.
This document provides guidance for writing learning objectives for Advanced Clinical Electives (ACEs) or Acting Internships (AIs) at Vanderbilt University School of Medicine. It aims to equip course directors with tools to write objectives using a standardized format. The document defines a learning objective as a clear target for learners to acquire new knowledge, skills, or attitudes. It also assumes course directors will want to increase their knowledge about constructing learning objectives and understand why they are essential elements of a course curriculum.
The document provides guidance on writing learning objectives for an educator development program at Vanderbilt School of Medicine. It discusses considering the categories/domains of objectives, components that comprise objectives, and verbs commonly used. Examples of objectives for an Immersion Course are provided. The document stresses writing objectives that are specific, measurable, attainable, relevant and time-sensitive. It indicates standardized objectives will be provided for different course types and instructors should create 2-4 additional course-specific objectives.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...Donc Test
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
RWJ Foundation at: http://www.rwjf.org/en/blogs/new-public-health/2014/10/drug_abuse_controlg.html – Accessed 1/9/2015
(One DCP update vol2;iss5, June 2011)
http://www.rwjf.org/en/research-publications/find-rwjf-research/2012/01/substance-abuse-policy-research-program.html
Problem Synopsis: According to a 2001 report from researchers at Brandeis University,
Last accessed 1/9/2015
SAMHSA at http://www.samhsa.gov/
Bollinger 2005 article: http://www.casacolumbia.org/addiction-research/reports/under-the-counter-diversion-abuse-controlled-perscription-drugs
CASA at http://www.casacolumbia.org/
Manchikanti 2007 Article: http://www.cfbhn.org/Documents/RX/National%20Drug%20Control%20Policy%20and%20Prescription%20Drug%20Abuse%20Facts%20and%20Fallacies.pdf
2011
2011
Men vs women opioid OD: http://www.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/
http://www.cdc.gov/homeandrecreationalsafety/rxbrief/
2011
2011
2011
Add audio describing the table – physician misprescribing makes up most of excess CPD
2011
Center on Addiction and Substance Abuse (CASA). 2005. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the US. New York: The National Center on Addiction and Substance Abuse (CASA).
http://www.casacolumbia.org/addiction-research/reports/under-the-counter-diversion-abuse-controlled-perscription-drugs
U.S. Department of Justice, Drug Enforcement Administration, Prescription Accountability Resource Guide, September 1998, <http://www.deadiversion.usdoj.gov/pubs/program/rx_account/index.html > (5 January 2004).
9th annual CPD take back day 2014 – last accessed 1/9/2015: http://www.dea.gov/divisions/hq/2014/hq110514.shtml
1. Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of Psychoactive Drugs. 2012; 44(22641969):79-85.
2. Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152: 613-616.
1. Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of Psychoactive Drugs. 2012; 44(22641969):79-85.
2. Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152: 613-616.
FSMB Modern Medical Practice act guide: http://library.fsmb.org/centennial/pdf/essentials-1970.pdf and the osteopathic 2012 version at: http://library.fsmb.org/pdf/GRPOL_essentials.pdf
https://health.state.tn.us/boards/Me/